CN Stock MarketDetailed Quotes

688105 Nanjing Vazyme Biotech

Watchlist
  • 23.04
  • -0.06-0.26%
Market Closed Dec 27 15:00 CST
9.27BMarket Cap390.51P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-96.02%75.43M
-72.45%541.92M
-14.91%1.36B
27.34%1.97B
98.72%1.89B
120.78%1.97B
89.76%1.6B
4.52%1.54B
422.07%953.49M
78.16%891.01M
Transactional financial assets
54.75%2.4B
31.67%2.04B
-23.52%1.68B
-11.94%1.51B
-16.06%1.55B
-22.06%1.55B
-5.51%2.2B
-12.99%1.72B
107.24%1.85B
203.84%1.99B
Notes receivable and accounts receivable
65.62%491.55M
65.29%471.56M
-20.00%400.47M
-58.04%351.65M
-54.02%296.8M
-42.12%285.29M
-1.74%500.6M
160.02%838.1M
69.06%645.52M
125.66%492.95M
-Notes receivable
--3.28M
--5.26M
----
----
----
----
----
----
----
--405.94K
-Accounts receivable
64.51%488.28M
63.45%466.31M
-20.00%400.47M
-58.04%351.65M
-54.02%296.8M
-42.08%285.29M
-1.64%500.6M
160.02%838.1M
69.06%645.52M
125.47%492.54M
Other receivables (including interest and dividends)
-14.24%4.04M
-36.13%3.39M
-28.64%3.94M
-38.79%3.25M
-88.83%4.71M
-28.17%5.3M
-62.55%5.52M
155.70%5.31M
1,084.48%42.22M
217.63%7.38M
-Other receivable
----
-36.13%3.39M
----
-38.79%3.25M
----
-28.17%5.3M
----
155.70%5.31M
----
217.63%7.38M
Advance payment
13.28%46.83M
-1.90%46.36M
-35.82%41.17M
-45.75%37.08M
-58.75%41.34M
-58.42%47.25M
-79.85%64.14M
222.18%68.35M
282.50%100.22M
308.66%113.64M
Inventories
-9.66%375.57M
-13.72%361.27M
-8.27%361.45M
-4.93%346.25M
-38.13%415.75M
-39.54%418.72M
-5.51%394.06M
50.38%364.2M
141.87%672.01M
176.29%692.53M
Receivable financing
3,947.72%17.42M
-19.14%8.16M
--3.03M
-81.86%276.17K
--430.31K
--10.09M
----
--1.52M
----
----
Other current assets
69.54%15.75M
12.11%15.94M
-76.74%10.94M
-54.31%10.86M
-58.93%9.29M
26.00%14.22M
604.70%47.04M
150.77%23.77M
42.78%22.62M
-4.99%11.29M
Total current assets
-18.69%3.43B
-18.84%3.49B
-19.66%3.87B
-7.34%4.23B
-1.63%4.21B
2.41%4.3B
8.47%4.81B
12.69%4.57B
140.73%4.28B
151.96%4.19B
Non Current assets
Other non-current financial assets
10.64%52.3M
134.53%52.33M
133.55%52.11M
111.96%47.3M
--47.27M
--22.31M
--22.31M
--22.31M
----
----
Fixed assets
----
-6.75%456.16M
----
15.76%476.3M
----
26.11%489.19M
----
105.08%411.47M
----
170.12%387.89M
Constru in process
----
-12.49%69.89M
----
83.57%127.48M
----
-63.45%79.86M
----
--69.44M
----
--218.51M
Intangible assets
-3.39%95.03M
-1.43%97.15M
97.36%98.45M
103.71%101.24M
156.60%98.36M
429.08%98.56M
196.91%49.88M
198.49%49.7M
159.05%38.33M
43.35%18.63M
Goodwill
0.00%130.49M
0.00%130.49M
0.00%130.49M
0.00%130.49M
-0.10%130.49M
--130.49M
--130.49M
--130.49M
--130.62M
----
Long deferred expense
4.11%295.78M
6.21%307.57M
-0.22%310.41M
-11.87%280.54M
37.69%284.1M
123.98%289.59M
128.94%311.09M
119.53%318.31M
48.04%206.34M
-11.77%129.29M
Deferred tax assets
29.87%127.05M
29.84%116.65M
49.58%113.75M
58.69%106.51M
267.93%97.83M
336.32%89.84M
213.62%76.05M
169.89%67.12M
7.45%26.59M
46.54%20.59M
Usufruct assets
64.16%212.89M
35.58%225.32M
19.50%216.88M
-17.64%163.53M
-39.49%129.68M
-17.28%166.19M
36.01%181.49M
83.27%198.57M
135.45%214.32M
109.38%200.9M
Other non current assets
-66.79%34.37M
-60.05%37.49M
-64.79%73.63M
-52.21%82.53M
-65.24%103.48M
-66.68%93.82M
-51.59%209.11M
308.75%172.69M
723.01%297.69M
652.95%281.55M
Total non current assets
-1.81%1.47B
2.27%1.49B
2.72%1.55B
5.26%1.52B
-6.45%1.5B
14.59%1.46B
47.24%1.51B
158.90%1.44B
213.95%1.6B
170.92%1.27B
Total assets
-14.26%4.9B
-13.48%4.98B
-14.32%5.41B
-4.31%5.75B
-2.94%5.71B
5.25%5.76B
15.74%6.32B
30.35%6.01B
157.05%5.89B
156.14%5.47B
Liabilities
Current liabilities
Short term loan
-60.89%456.78M
-59.10%472.34M
-12.32%884.67M
316.58%1.13B
483.92%1.17B
--1.15B
--1.01B
--272.21M
--200M
----
Notes payable and accounts payable
-48.91%83.31M
-40.54%104.74M
-49.86%122.23M
-53.94%146.82M
-55.87%163.07M
-47.48%176.14M
-37.65%243.77M
168.44%318.78M
293.56%369.53M
228.81%335.34M
-Notes payable
----
-37.45%15.04M
22.50%15.04M
----
-99.47%764.5K
-78.43%24.04M
--12.28M
--25.9M
--143.77M
--111.43M
-Accounts payable
-48.67%83.31M
-41.02%89.7M
-53.70%107.19M
-49.87%146.82M
-28.11%162.3M
-32.07%152.1M
-40.79%231.49M
146.62%292.88M
140.44%225.76M
119.55%223.91M
Contract liabilities
-13.01%37.61M
-33.56%44.69M
-67.19%43.87M
-73.94%55.92M
-59.87%43.24M
-36.36%67.27M
-17.77%133.7M
125.76%214.55M
24.77%107.74M
26.63%105.7M
Salaries payable
8.71%80.5M
7.49%76.5M
-21.75%61.27M
-45.22%103.43M
-30.28%74.05M
-20.34%71.17M
42.98%78.29M
97.02%188.81M
138.22%106.22M
166.96%89.34M
Taxs payable
-16.77%12.21M
-21.94%9.32M
-14.18%8.03M
-78.89%17.47M
-50.63%14.68M
-79.59%11.94M
-91.49%9.36M
119.06%82.76M
-28.80%29.72M
22.12%58.51M
Other payable (including interest and dividends)
140.62%12.61M
69.54%10.28M
71.00%9.09M
160.83%13.9M
-54.76%5.24M
-55.25%6.06M
-47.34%5.32M
-30.61%5.33M
278.69%11.59M
328.44%13.55M
-Dividend payable
----
----
----
----
----
----
----
----
----
--4.47M
-Other payable
----
69.54%10.28M
----
160.83%13.9M
----
-33.17%6.06M
----
-30.61%5.33M
----
186.92%9.07M
Non current liabilities due within one year
-27.26%44.15M
-36.63%38.49M
-7.39%50.25M
-20.75%46.16M
-9.16%60.7M
-14.25%60.73M
35.58%54.26M
86.42%58.25M
167.91%66.81M
167.51%70.83M
Other current liabilities
652.39%4.04M
556.61%7M
-73.48%1.44M
-86.26%1.84M
-43.96%537.47K
-68.18%1.07M
--5.44M
1,340.09%13.37M
35.45%959.1K
186.63%3.35M
Total current liabilities
-52.19%731.22M
-50.73%763.35M
-23.28%1.18B
31.66%1.52B
71.34%1.53B
128.97%1.55B
100.32%1.54B
198.01%1.15B
202.27%892.57M
127.33%676.63M
Current liabilities
Estimate liabilities
-71.10%18.51M
-70.75%17.63M
-31.08%53.24M
-16.45%67.6M
395.99%64.03M
292.01%60.28M
280.08%77.24M
421.23%80.92M
-57.87%12.91M
-44.34%15.38M
Deferred tax liabilities
-74.43%1.32M
-55.10%1.23M
-52.30%1.51M
-86.49%1.51M
-87.04%5.17M
81.26%2.74M
42.59%3.17M
1,179.32%11.19M
3,960.49%39.89M
167.78%1.51M
Long term deferred income
167.39%49.27M
157.27%48.75M
46.60%32.8M
11.06%21.38M
-18.84%18.43M
-17.10%18.95M
-4.86%22.37M
18.58%19.25M
25.14%22.71M
24.48%22.86M
Lease liabilities
105.19%159.11M
60.03%172.37M
17.11%147.29M
-16.28%106.89M
-48.55%77.54M
-15.64%107.71M
49.64%125.76M
113.03%127.68M
167.09%150.71M
102.58%127.68M
Total non current liabilities
38.17%228.21M
26.52%239.98M
2.75%234.83M
-17.42%197.39M
-26.99%165.17M
13.29%189.69M
75.67%228.54M
158.23%239.03M
113.02%226.22M
52.78%167.43M
Total liabilities
-43.38%959.43M
-42.30%1B
-19.91%1.42B
23.24%1.72B
51.46%1.69B
106.02%1.74B
96.75%1.77B
190.33%1.39B
178.66%1.12B
107.27%844.05M
Shareholders equity
Paid-in capital
0.00%400.01M
0.00%400.01M
0.00%400.01M
0.00%400.01M
0.00%400.01M
0.00%400.01M
0.00%400.01M
0.00%400.01M
11.11%400.01M
11.11%400.01M
Capital reserve funds
2.22%2.48B
2.24%2.48B
1.85%2.46B
0.54%2.44B
-0.20%2.42B
-0.19%2.42B
-0.22%2.42B
0.30%2.43B
592.12%2.43B
594.96%2.43B
Surplus reserve funds
0.00%200.01M
0.00%200.01M
0.00%200.01M
0.00%200.01M
68.72%200.01M
68.72%200.01M
68.72%200.01M
68.72%200.01M
126.05%118.54M
126.05%118.54M
Retained profit
-1.59%987.25M
2.63%1.02B
-33.69%1.01B
-36.15%1.01B
-44.77%1B
-40.59%998.48M
-5.51%1.53B
33.10%1.58B
61.49%1.82B
73.90%1.68B
Less:Treasury stock
2,066.14%124.04M
--120.03M
--76.9M
--20.01M
--5.73M
----
----
----
----
----
Other composite income
81.42%-582.9K
27.96%-2.42M
-236.56%-1.96M
---1.72M
---3.14M
---3.36M
--1.43M
----
----
----
Shareholders equity without minority interests
-1.94%3.94B
-0.96%3.98B
-12.11%4B
-12.57%4.03B
-15.65%4.02B
-13.17%4.02B
-0.25%4.55B
11.67%4.61B
152.26%4.76B
167.66%4.62B
Minority interests
-365.10%-1.25M
-206.24%-959.24K
-125.27%-448.46K
-103.35%-107.36K
-87.18%471.42K
41,608,306.91%902.9K
91,956,839.90%1.77M
4,001,028,212.50%3.2M
--3.68M
---2.17
Total shareholder equity
-1.98%3.94B
-1.01%3.98B
-12.15%4B
-12.64%4.03B
-15.71%4.02B
-13.15%4.02B
-0.22%4.55B
11.75%4.61B
152.45%4.77B
167.66%4.62B
Total liabilityies and equity
-14.26%4.9B
-13.48%4.98B
-14.32%5.41B
-4.31%5.75B
-2.94%5.71B
5.25%5.76B
15.74%6.32B
30.35%6.01B
157.05%5.89B
156.14%5.47B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -96.02%75.43M-72.45%541.92M-14.91%1.36B27.34%1.97B98.72%1.89B120.78%1.97B89.76%1.6B4.52%1.54B422.07%953.49M78.16%891.01M
Transactional financial assets 54.75%2.4B31.67%2.04B-23.52%1.68B-11.94%1.51B-16.06%1.55B-22.06%1.55B-5.51%2.2B-12.99%1.72B107.24%1.85B203.84%1.99B
Notes receivable and accounts receivable 65.62%491.55M65.29%471.56M-20.00%400.47M-58.04%351.65M-54.02%296.8M-42.12%285.29M-1.74%500.6M160.02%838.1M69.06%645.52M125.66%492.95M
-Notes receivable --3.28M--5.26M------------------------------405.94K
-Accounts receivable 64.51%488.28M63.45%466.31M-20.00%400.47M-58.04%351.65M-54.02%296.8M-42.08%285.29M-1.64%500.6M160.02%838.1M69.06%645.52M125.47%492.54M
Other receivables (including interest and dividends) -14.24%4.04M-36.13%3.39M-28.64%3.94M-38.79%3.25M-88.83%4.71M-28.17%5.3M-62.55%5.52M155.70%5.31M1,084.48%42.22M217.63%7.38M
-Other receivable -----36.13%3.39M-----38.79%3.25M-----28.17%5.3M----155.70%5.31M----217.63%7.38M
Advance payment 13.28%46.83M-1.90%46.36M-35.82%41.17M-45.75%37.08M-58.75%41.34M-58.42%47.25M-79.85%64.14M222.18%68.35M282.50%100.22M308.66%113.64M
Inventories -9.66%375.57M-13.72%361.27M-8.27%361.45M-4.93%346.25M-38.13%415.75M-39.54%418.72M-5.51%394.06M50.38%364.2M141.87%672.01M176.29%692.53M
Receivable financing 3,947.72%17.42M-19.14%8.16M--3.03M-81.86%276.17K--430.31K--10.09M------1.52M--------
Other current assets 69.54%15.75M12.11%15.94M-76.74%10.94M-54.31%10.86M-58.93%9.29M26.00%14.22M604.70%47.04M150.77%23.77M42.78%22.62M-4.99%11.29M
Total current assets -18.69%3.43B-18.84%3.49B-19.66%3.87B-7.34%4.23B-1.63%4.21B2.41%4.3B8.47%4.81B12.69%4.57B140.73%4.28B151.96%4.19B
Non Current assets
Other non-current financial assets 10.64%52.3M134.53%52.33M133.55%52.11M111.96%47.3M--47.27M--22.31M--22.31M--22.31M--------
Fixed assets -----6.75%456.16M----15.76%476.3M----26.11%489.19M----105.08%411.47M----170.12%387.89M
Constru in process -----12.49%69.89M----83.57%127.48M-----63.45%79.86M------69.44M------218.51M
Intangible assets -3.39%95.03M-1.43%97.15M97.36%98.45M103.71%101.24M156.60%98.36M429.08%98.56M196.91%49.88M198.49%49.7M159.05%38.33M43.35%18.63M
Goodwill 0.00%130.49M0.00%130.49M0.00%130.49M0.00%130.49M-0.10%130.49M--130.49M--130.49M--130.49M--130.62M----
Long deferred expense 4.11%295.78M6.21%307.57M-0.22%310.41M-11.87%280.54M37.69%284.1M123.98%289.59M128.94%311.09M119.53%318.31M48.04%206.34M-11.77%129.29M
Deferred tax assets 29.87%127.05M29.84%116.65M49.58%113.75M58.69%106.51M267.93%97.83M336.32%89.84M213.62%76.05M169.89%67.12M7.45%26.59M46.54%20.59M
Usufruct assets 64.16%212.89M35.58%225.32M19.50%216.88M-17.64%163.53M-39.49%129.68M-17.28%166.19M36.01%181.49M83.27%198.57M135.45%214.32M109.38%200.9M
Other non current assets -66.79%34.37M-60.05%37.49M-64.79%73.63M-52.21%82.53M-65.24%103.48M-66.68%93.82M-51.59%209.11M308.75%172.69M723.01%297.69M652.95%281.55M
Total non current assets -1.81%1.47B2.27%1.49B2.72%1.55B5.26%1.52B-6.45%1.5B14.59%1.46B47.24%1.51B158.90%1.44B213.95%1.6B170.92%1.27B
Total assets -14.26%4.9B-13.48%4.98B-14.32%5.41B-4.31%5.75B-2.94%5.71B5.25%5.76B15.74%6.32B30.35%6.01B157.05%5.89B156.14%5.47B
Liabilities
Current liabilities
Short term loan -60.89%456.78M-59.10%472.34M-12.32%884.67M316.58%1.13B483.92%1.17B--1.15B--1.01B--272.21M--200M----
Notes payable and accounts payable -48.91%83.31M-40.54%104.74M-49.86%122.23M-53.94%146.82M-55.87%163.07M-47.48%176.14M-37.65%243.77M168.44%318.78M293.56%369.53M228.81%335.34M
-Notes payable -----37.45%15.04M22.50%15.04M-----99.47%764.5K-78.43%24.04M--12.28M--25.9M--143.77M--111.43M
-Accounts payable -48.67%83.31M-41.02%89.7M-53.70%107.19M-49.87%146.82M-28.11%162.3M-32.07%152.1M-40.79%231.49M146.62%292.88M140.44%225.76M119.55%223.91M
Contract liabilities -13.01%37.61M-33.56%44.69M-67.19%43.87M-73.94%55.92M-59.87%43.24M-36.36%67.27M-17.77%133.7M125.76%214.55M24.77%107.74M26.63%105.7M
Salaries payable 8.71%80.5M7.49%76.5M-21.75%61.27M-45.22%103.43M-30.28%74.05M-20.34%71.17M42.98%78.29M97.02%188.81M138.22%106.22M166.96%89.34M
Taxs payable -16.77%12.21M-21.94%9.32M-14.18%8.03M-78.89%17.47M-50.63%14.68M-79.59%11.94M-91.49%9.36M119.06%82.76M-28.80%29.72M22.12%58.51M
Other payable (including interest and dividends) 140.62%12.61M69.54%10.28M71.00%9.09M160.83%13.9M-54.76%5.24M-55.25%6.06M-47.34%5.32M-30.61%5.33M278.69%11.59M328.44%13.55M
-Dividend payable --------------------------------------4.47M
-Other payable ----69.54%10.28M----160.83%13.9M-----33.17%6.06M-----30.61%5.33M----186.92%9.07M
Non current liabilities due within one year -27.26%44.15M-36.63%38.49M-7.39%50.25M-20.75%46.16M-9.16%60.7M-14.25%60.73M35.58%54.26M86.42%58.25M167.91%66.81M167.51%70.83M
Other current liabilities 652.39%4.04M556.61%7M-73.48%1.44M-86.26%1.84M-43.96%537.47K-68.18%1.07M--5.44M1,340.09%13.37M35.45%959.1K186.63%3.35M
Total current liabilities -52.19%731.22M-50.73%763.35M-23.28%1.18B31.66%1.52B71.34%1.53B128.97%1.55B100.32%1.54B198.01%1.15B202.27%892.57M127.33%676.63M
Current liabilities
Estimate liabilities -71.10%18.51M-70.75%17.63M-31.08%53.24M-16.45%67.6M395.99%64.03M292.01%60.28M280.08%77.24M421.23%80.92M-57.87%12.91M-44.34%15.38M
Deferred tax liabilities -74.43%1.32M-55.10%1.23M-52.30%1.51M-86.49%1.51M-87.04%5.17M81.26%2.74M42.59%3.17M1,179.32%11.19M3,960.49%39.89M167.78%1.51M
Long term deferred income 167.39%49.27M157.27%48.75M46.60%32.8M11.06%21.38M-18.84%18.43M-17.10%18.95M-4.86%22.37M18.58%19.25M25.14%22.71M24.48%22.86M
Lease liabilities 105.19%159.11M60.03%172.37M17.11%147.29M-16.28%106.89M-48.55%77.54M-15.64%107.71M49.64%125.76M113.03%127.68M167.09%150.71M102.58%127.68M
Total non current liabilities 38.17%228.21M26.52%239.98M2.75%234.83M-17.42%197.39M-26.99%165.17M13.29%189.69M75.67%228.54M158.23%239.03M113.02%226.22M52.78%167.43M
Total liabilities -43.38%959.43M-42.30%1B-19.91%1.42B23.24%1.72B51.46%1.69B106.02%1.74B96.75%1.77B190.33%1.39B178.66%1.12B107.27%844.05M
Shareholders equity
Paid-in capital 0.00%400.01M0.00%400.01M0.00%400.01M0.00%400.01M0.00%400.01M0.00%400.01M0.00%400.01M0.00%400.01M11.11%400.01M11.11%400.01M
Capital reserve funds 2.22%2.48B2.24%2.48B1.85%2.46B0.54%2.44B-0.20%2.42B-0.19%2.42B-0.22%2.42B0.30%2.43B592.12%2.43B594.96%2.43B
Surplus reserve funds 0.00%200.01M0.00%200.01M0.00%200.01M0.00%200.01M68.72%200.01M68.72%200.01M68.72%200.01M68.72%200.01M126.05%118.54M126.05%118.54M
Retained profit -1.59%987.25M2.63%1.02B-33.69%1.01B-36.15%1.01B-44.77%1B-40.59%998.48M-5.51%1.53B33.10%1.58B61.49%1.82B73.90%1.68B
Less:Treasury stock 2,066.14%124.04M--120.03M--76.9M--20.01M--5.73M--------------------
Other composite income 81.42%-582.9K27.96%-2.42M-236.56%-1.96M---1.72M---3.14M---3.36M--1.43M------------
Shareholders equity without minority interests -1.94%3.94B-0.96%3.98B-12.11%4B-12.57%4.03B-15.65%4.02B-13.17%4.02B-0.25%4.55B11.67%4.61B152.26%4.76B167.66%4.62B
Minority interests -365.10%-1.25M-206.24%-959.24K-125.27%-448.46K-103.35%-107.36K-87.18%471.42K41,608,306.91%902.9K91,956,839.90%1.77M4,001,028,212.50%3.2M--3.68M---2.17
Total shareholder equity -1.98%3.94B-1.01%3.98B-12.15%4B-12.64%4.03B-15.71%4.02B-13.15%4.02B-0.22%4.55B11.75%4.61B152.45%4.77B167.66%4.62B
Total liabilityies and equity -14.26%4.9B-13.48%4.98B-14.32%5.41B-4.31%5.75B-2.94%5.71B5.25%5.76B15.74%6.32B30.35%6.01B157.05%5.89B156.14%5.47B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme The Concept of in Vitro Diagnosis
The Concept of in Vitro Diagnosis
Intraday+0.64%
Gene Sequencing
Gene Sequencing
Intraday+0.63%
Medical Device Concept
Medical Device Concept
Intraday+0.35%